News

The U.S. Supreme Court's 2024 ruling in the Purdue Pharma bankruptcy cases generally prohibiting nonconsensual releases of non-debtors in chapter ...
Alaska signed on to a $7.4 billion national Purdue settlement last month, which could bring the state more than $12 million.
For starters, they should use Purdue Pharma’s billions to make Narcan universally accessible. State and local governments are ...
SEATTLE — The Attorney General’s Office started today a sign-on process for city and county governments across Washington to join recent opioid settlements of up to $122.2 million with Purdue Pharma ...
Purdue Pharma began marketing OxyContin in 1996 after winning approval from the Food and Drug Administration. In the first few years it was used as a prescription painkiller, only a few sporadic ...
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...
OxyContin maker Purdue Pharma ‘s latest plan to settle thousands of lawsuits over the toll of opioids could soon move forward after every U.S. state involved agreed to it. A judge on Wednesday ...
Purdue Pharma bankruptcy plan, which would give Sackler family immunity, moves forward. The company can begin soliciting support for its Chapter 11 reorganization plan.
Purdue Pharma has won support from the attorneys general of 55 U.S. states and territories for its $7.4 billion settlement to resolve thousands of opioid lawsuits against the drugmaker and its owners, ...
Purdue Pharma, a pharmaceutical company facing an onslaught of litigation for allegedly contributing to the opioid crisis, filed for bankruptcy on Sunday as part of a tentative, yet controversial ...
Purdue Pharma, the maker of the painkiller OxyContin, said it has filed for bankruptcy as part of a plan to settle lawsuits accusing the company of fueling the opioid crisis.